Shakthi Kumaran Ramasamy

Dr. Shakthi Kumaran Ramasamy

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
ACArum Choi
Arum Choi
HKHyun Gi Kim
Hyun Gi Kim
MCMoon-hyung Choi
Moon-hyung Choi
SRShakthi Kumaran Ramasamy
Shakthi Kumaran Ramasamy
YKYoume Kim
Youme Kim
SJSeung Eun Jung
Seung Eun Jung
Choi A, et al. Korean J Radiol. 2025 Apr;26:e46. https://doi.org/10.3348/kjr.2024.1096

1 June 2023 in Radiology
Verified
Journal Article
Closed access
SRShakthi Kumaran Ramasamy
Shakthi Kumaran Ramasamy

7 March 2026 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Open access
GNGovindarajan Narayanan
Govindarajan Narayanan
ERElizabeth Mary Ruiz
Elizabeth Mary Ruiz
MDMadelon Dijkstra
Madelon Dijkstra
BBBente van den Bemd
Bente van den Bemd
AMAshwin Mahendra
Ashwin Mahendra
SLSusan van der Lei
Susan van der Lei
To evaluate the safety and accuracy of robot-assisted microwave ablation (MWA) for primary and secondary liver tumors using the Epione (Quantum Surgical, Montpellier, France) robotic system. This single-center retrospective study included all computed tomography (CT)-guided robotic MWA procedures performed at the Miami Cancer Institute, Baptist Health South Florida from May 2023 to March 2025. Primary endpoints were safety, assessed by adverse events related to robotic guidance or ablation, and accuracy, defined by the need for minor (depth/lateral) or major (antenna removal and reinsertion) adjustments. Secondary endpoints included feasibility, technical success, local tumor progression (LTP), LTP-free survival (LTPFS), and local control (LC). A total of 153 robot-assisted antenna placements were performed to treat 152 tumors in 78 patients. Robotic placement was feasible in 98.7% (77/78) of patients. Technical success was achieved in 96.8% (152/157) of trajectories. Among all trajectories, 18.5% (29/157) required no adjustment, 62.4% (98/157) required minor depth adjustment, 17.8% (28/157) required minor lateral adjustment, and 3.2% (5/157) required major adjustment. Of major adjustments, 4 were corrected with robotic reinsertion, and 1 was corrected manually. Mean preadjustment lateral deviation was 5.6 mm (SD ±3.9). Adverse events occurred in 14.1% (11 Grade 1, 2 Grade 2, and 1 Grade 3) of procedures, none directly related to robotic guidance. Median follow-up was 6.9 months. The 6-month LTPFS per tumor for patients treated in the first versus second year was 87.1% versus 94.9%, respectively (hazard ratio, 0.385; 95% confidence interval, 0.083-1.771; P = .220). Robotic guidance for liver MWA demonstrated high feasibility, excellent technical success, and low placement error with no robot-related complications, supporting its safety and accuracy in clinical practice.

1 January 2026 in Radiology
Verified
Journal Article
Closed access
SRShakthi Kumaran Ramasamy
Shakthi Kumaran Ramasamy
ABAmanda Baker
Amanda Baker

26 November 2024 in Current Problems in Diagnostic Radiology
Verified
Journal Article
Closed access
SRShakthi Kumaran Ramasamy
Shakthi Kumaran Ramasamy
JYJung H Yun
Jung H Yun
RDRui Dai
Rui Dai
SLShiyi Li
Shiyi Li
XWXiao Wu
Xiao Wu
DDDania Daye
Dania Daye

1 January 2026 in RadioGraphics
Verified
Journal Article
Closed access
KMKathleen H. Miao
Kathleen H. Miao
SRShakthi Kumaran Ramasamy
Shakthi Kumaran Ramasamy
AWAtlee Witt
Atlee Witt
PBPavan Brahmbhatt
Pavan Brahmbhatt
JMJulia H. Miao
Julia H. Miao